文献速递瓣膜外科

经导管主动脉瓣置换术后院内卒中风险预测模型的开发与应用

Development and Application of a Risk Prediction Model for In-Hospital Stroke After Transcatheter Aortic Valve Replacement: A Report From The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.
PubMed 文献 · Ann Thorac Surg · 2018-12-07

基于胸外科医师学会/美国心脏病学会经导管瓣膜治疗注册登记,纳入2014年7月至2017年6月521个中心的97,600例TAVR手术,用逻辑回归建立院内卒中风险模型。院内卒中发生1,839例(1.9%),C统计量为0.622,校准曲线示观察与预期卒中率一致,层次模型显示10个中心(1.9%)风险校正后院内卒中比值比显著高于同行。

要点

  • 经股动脉以外入路、既往卒中和TIA史与TAVR术后院内卒中风险升高相关。
  • 模型区分度有限(C统计量0.622),可用于质量改进、临床决策与患者沟通。
  • 层次模型可识别院内卒中风险校正后表现显著异常的中心。

核心结论

  • 从STS/ACC TVT注册登记开发了TAVR术后院内卒中风险模型,并用于评估各中心的风险校正表现。

研究设计与样本

  • 基于STS/ACC TVT注册登记2014年7月至2017年6月521个中心的97,600例TAVR手术,采用逻辑回归建模,C统计量评价区分度,交叉验证内部校准,层次模型估计风险校正的中心表现。

主要发现

  • 中位年龄82岁,女性44,926例(46.0%),院内卒中1,839例(1.9%)。
  • 与卒中相关的协变量(比值比)包括经心尖入路1.44、非经心尖及非经股动脉入路1.77、既往卒中1.57、既往短暂性脑缺血发作1.50、术前休克/正性肌力药/机械辅助装置1.48、吸烟1.28、瓷化主动脉1.23、外周动脉疾病1.21、年龄每5岁1.11、肾小球滤过率每5 mL/min 0.97、体表面积每m2男性0.55、女性0.43、既往主动脉瓣手术0.78、既往非主动脉瓣膜手术0.42。
  • C统计量为0.622,校准曲线示观察与预期卒中率一致。
  • 层次模型显示10个中心(1.9%)院内卒中比值比显著高于同行。

临床怎么用

  • 该模型可用于TAVR术后院内卒中的质量改进、临床决策和患者咨询,并辅助识别卒中表现异常的中心。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Stroke is a serious complication after transcatheter aortic valve replacement (TAVR), yet predictive models are not available. A new risk model for in-hospital stroke after TAVR was developed and used to estimate site-specific performance. METHODS: We included 97,600 TAVR procedures from 521 sites in The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry from July 2014 to June 2017. Association between baseline covariates and in-hospital stroke was estimated by logistic regression. Discrimination was evaluated by C-statistic. Calibration was tested internally via cross-validation. Hierarchical modeling was used to estimate risk-adjusted site-specific performance. RESULTS: Median age was 82 years, 44,926 (46.0%) were women, and 1,839 (1.9%) had in-hospital stroke. Covariates associated with stroke (odds ratio) included transapical access (1.44), access excluding transapical and transfemoral (1.77), prior stroke (1.57), prior transient ischemic attack (1.50), preprocedural shock, inotropes or mechanical assist device (1.48), smoking (1.28), porcelain aorta (1.23), peripheral arterial disease (1.21), age per 5 years (1.11), glomerular filtration rate per 5 mL/min (0.97), body surface area per m2 (0.55 male; 0.43 female), and prior aortic valve (0.78) and nonaortic valvular (0.42) procedures. The C-statistic was 0.622. Calibration curves demonstrated agreement between observed and expected stroke rates. Hierarchical modeling showed 10 (1.9%) centers with significantly higher odds ratios for in-hospital stroke than their peers. CONCLUSIONS: A risk model for in-hospital stroke after TAVR was developed from The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry and used to estimate site-specific stroke performance. This model can serve as a valuable resource for quality improvement, clinical decision making, and patient counseling.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Thourani VH, O'Brien SM, Kelly JJ, et al. Development and Application of a Risk Prediction Model for In-Hospital Stroke After Transcatheter Aortic Valve Replacement: A Report From The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. Ann Thorac Surg. 2018. PMID: 30529671. doi:10.1016/j.athoracsur.2018.11.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。